Asian Pacific Journal of Cancer Prevention

  • 제15권6호
  • /
  • Pages.2647-2650
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Pretreatment Neutrophil/Lymphocyte Ratio as a Prognostic Aid in Colorectal Cancer

  • Ozdemir, Yavuz (Department of Surgery, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital) ;
  • Akin, Mehmet Levhi (Department of Surgery, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital) ;
  • Sucullu, Ilker (Department of Surgery, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital) ;
  • Balta, Ahmet Ziya (Department of Surgery, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital) ;
  • Yucel, Ergun (Department of Surgery, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital)
  • 발행 : 2014.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Colorectal cancers(CRC) are the third most common cancer in the western world, with surgery preferred for management of non-metastatic disease and post surgical treatment usually arranged according to the TNM staging system. However, there is still prognostic variation between patients who have the same stage. It is increasingly recognized that variations within disease course and clinical outcome in colorectal cancer patients are influenced by not only oncological characteristics of the tumor itself but also host response factors. Recent studies have shown correlation between the inflammatory response and clinical outcomes in various cancers. The neutrophil/lymphocyte ratio (NLR) has been described as a marker for immune response to various stimuli including cancer. Material-Methods: Two hundred eighty-one CRC patients were included in our retrospective analysis, separated into two groups according to a cut-off value for the NLR. Patient data including age, gender, vertical penetration, anatomic location, and differentiation of the tumor, TNM stage, survival rate, and disease-free survival were analyzed for correlations with the NLR. Results: Using ROC curve analysis, we determined a cut-off value of 2.2 for NLR to be best to discriminate between patient survival in the whole group. In univariate analysis, high pretreatment NLR (p=0.001, 95%CI 1.483-4.846), pathologic nodal stage (p<0.001, 95%CI 1.082-3.289) and advanced pathologic TNM stage (p<0.001, 95%CI 1.462-4.213) were predictive of shorter survival. In multivariate analysis, advanced pathologic TNM stage (p=0.001, 95%CI 1.303-26.542) and high pretreatment NLR (p=0.005, 95%CI 1.713-6.378) remained independently associated with poor survival. Conclusions: High pre-treatment NLR is a significant independent predictor of shorter survival in patients with colorectal cancer. This parameter is a simple, easily accessible laboratory value for identifying patients with poorer prognosis.

키워드

참고문헌

  1. Absenger G, Szkandera J, Stotz M, et al (2013) Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer. Anticancer Res, 33, 4591-4.
  2. Aliustaoglu M, Bilici A, Seker M, et al (2010). The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer. Hepatogastroenterology. 57, 640-5.
  3. American Cancer Society (2013). Cancer Facts and Figures 2013. Atlanta, Ga: American Cancer Society, Also available online. Last accessed January 22, 2013.
  4. Azab B, Bhatt VR, Phookan J, et al (2012). Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol, 19, 217-24. https://doi.org/10.1245/s10434-011-1814-0
  5. Bolocan A, Ion D, Ciocan DN, Paduraru DN (2012). Prognostic and predictive factors in colorectal cancer. Chirurgia (Bucur). 107, 555-63.
  6. Cedres S, Torrejon D, Martinez A, et al (2012). Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol, 14, 864-9. https://doi.org/10.1007/s12094-012-0872-5
  7. Chiang SF, Hung HY, Tang R, et al (20129. Can neutrophil-tolymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis, 27, 1347-57. https://doi.org/10.1007/s00384-012-1459-x
  8. Cho H, Hur HW, Kim SW, et al (2009). Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother, 58, 15-23. https://doi.org/10.1007/s00262-008-0516-3
  9. De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, et al (2006). Prognostic value of the lymph node ratio in node positive colon cancer. Gut, 55, 1681 https://doi.org/10.1136/gut.2006.104117
  10. Ding PR, An X, Zhang RX, et al (2010). Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis, 25, 1427-33. https://doi.org/10.1007/s00384-010-1052-0
  11. Halazun KJ, Aldoori A, Malik HZ, et al (2008). Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol, 34, 55-60. https://doi.org/10.1016/j.ejso.2007.02.014
  12. He W, Yin C, Guo G, et al (2013). Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol, 30, 439. https://doi.org/10.1007/s12032-012-0439-x
  13. Hung HY, Chen JS, Yeh, et al (2011). Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis, 26, 1059-65. https://doi.org/10.1007/s00384-011-1192-x
  14. Jung MR, Park YK, Jeong O, et al (2011). Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stagegastric cancer. J Surg Oncol, 104, 504-10. https://doi.org/10.1002/jso.21986
  15. Kao SC, Pavlakis N, Harvie R, et al (2010). High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res, 16, 5805-13. https://doi.org/10.1158/1078-0432.CCR-10-2245
  16. Kaya V, Yildirim M, Demirpence O, Yildiz M, Yalcin AY (2013). Prognostic significance of basic laboratory methods in nonsmall- cell-lung cancer. Asian Pac J Cancer Prev, 14, 5473-6. https://doi.org/10.7314/APJCP.2013.14.9.5473
  17. Kishi Y, Kopetz S, Chun YS, et al (2009). Blood neutrophil-tolymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol, 16, 614-22. https://doi.org/10.1245/s10434-008-0267-6
  18. Leitch EF, Chakrabarti M, Crozier JE, et al (2007). Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer, 97, 1266-70. https://doi.org/10.1038/sj.bjc.6604027
  19. Li MX, Liu XM, Zhang XF, et al (2013). Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer, (Epub ahead of print)
  20. Malietzis G, Giacometti M, Askari A, et al (2013). A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Ann Surg.(Epub ahead of print)
  21. Ownby HE, Roi LD, Isenberg RR, Brennan MJ (1983). Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer, 52, 126-30.
  22. Roxburgh CS, McMillan DC (2010). Role of systemic inflammatory response in predicting survival in patients with primer operable cancer. Future Oncol, 6, 149-63 https://doi.org/10.2217/fon.09.136
  23. Shin R, Jeong SY, Yoo HY, et al (2012). Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer. Dis Colon Rectum, 55, 1220-8. https://doi.org/10.1097/DCR.0b013e31826fea6a
  24. Strieter RM, Burdick MD, Mestas J, et al (2006). Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer. 42, 768-78 https://doi.org/10.1016/j.ejca.2006.01.006
  25. Suzuki O, Sekishita Y, Shiono T, et al (2006). Number of lymph node metastases is better predictor of prognosis than level of lymph node metastasis in patients with node-positive colon cancer. J Am Coll Surg, 202,732-6. https://doi.org/10.1016/j.jamcollsurg.2006.02.007
  26. Turkish Public Health Foundation, Cancer statistics 2009 ( http://www.kanser.gov.tr/haberler/921-2009-turkiye-kanseristatistikleri- yayimlandi.html)
  27. Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42. https://doi.org/10.7314/APJCP.2013.14.9.5237
  28. Waldner M, Schimanski CC, Neurath MF (2006). Colon cancer and the immune system: The role of tumor invading T cells. World J Gastroenterol, 12, 7233-38
  29. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005). Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol, 91, 181-4. https://doi.org/10.1002/jso.20329
  30. Zahorec R (2001). Ratio of neutrophil to lymphocyte counts-- rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102, 5-14.

피인용 문헌

  1. Treatment of Metastatic Colorectal Cancer With or Without Bevacizumab: Can the Neutrophil/Lymphocyte Ratio Predict the Efficiency of Bevacizumab? vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4781
  2. Recurrence Risk and Prognostic Parameters in Stage I Rectal Cancers vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5337
  3. Mean Platelet Volume as a Prognostic Marker in Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Combined Chemotherapy vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6421
  4. Prognostic Model Built on Blood-based Biomarkers in Patients with Metastatic Colorectal Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7327
  5. Elevated Neutrophil-to-Lymphocyte Ratio in Squamous Cell Carcinoma of Larynx Compared to Benign and Precancerous Laryngeal Lesions vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7351
  6. The Neutrophil to Lymphocyte Ratio has a High Negative Predictive Value for Pathologic Complete Response in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7737
  7. Diet and Colorectal Cancer Risk in Asia - a Systematic Review vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5389
  8. Adjuvant Chemotherapy and Prognostic Factors in Stage II Colon Cancer - Izmir Oncology Group Study vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2413
  9. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer vol.22, pp.S3, 2015, https://doi.org/10.1245/s10434-015-4571-7
  10. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease vol.36, pp.3, 2015, https://doi.org/10.1007/s10072-014-1976-1
  11. Prediction of chemotherapeutic efficacy using the ratio of neutrophils to lymphocytes in patients with unresectable or recurrent gastric cancer pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3575
  12. Pretreatment Neutrophil-Lymphocyte Ratio in Salivary Gland Tumors Is Associated with Malignancy vol.155, pp.6, 2016, https://doi.org/10.1177/0194599816659257
  13. The Neutrophil to Lymphocyte Ratio is an Independent Prognostic Factor in Patients with Metastatic Gastric Cancer vol.17, pp.3, 2016, https://doi.org/10.7314/APJCP.2016.17.3.1309
  14. levels predict the progression of colorectal cancer vol.5, pp.3, 2016, https://doi.org/10.1002/cam4.602
  15. Is it possible to predict the presence of colorectal cancer in a blood test? A probabilistic approach method vol.109, pp.1130-0108, 2017, https://doi.org/10.17235/reed.2017.4645/2016
  16. Platelet Distribution Width as a Predictor of Metastasis in Gastric Cancer Patients vol.48, pp.4, 2017, https://doi.org/10.1007/s12029-016-9886-5
  17. Analysis of prognostic factors of patients with malignant peritoneal mesothelioma vol.16, pp.1, 2018, https://doi.org/10.1186/s12957-018-1350-5
  18. Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis vol.17, pp.1533-0338, 2018, https://doi.org/10.1177/1533033818791500
  19. Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma vol.2019, pp.1687-630X, 2019, https://doi.org/10.1155/2019/7103915